- Furmonertinib re-challenge for epidermal growth factor recep... 2025-01-21
- Efficacy of disitamab vedotin-containing therapy in metastat... 2025-01-21
- Transmembrane channel-like 5 drives hepatocellular carcinoma... 2025-01-21
- Validation of the prognostic model for palliative radiothera... 2025-01-21
- Incorporation of human β-defensin-1 into immunoliposomes to ... 2025-01-21
World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJCO accepts both solicited and unsolicited manuscripts. Articles published in WJCO are high-quality, clinical and basic, influential research articles by established academic authors as well as new researchers. The paramount objective of WJCO is to showcase and promote distinguished research in the field of oncology, to help advance development of this field. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>
- Hiten RH Patel, BM BCh, BSc, FRCS, PhD, Professor, Surgical Oncologist, (E-mail: hrhpatel@hotmail.com) Department of Urology, University Hospital North Norway, Tromso 9038, Norway
The 2024 edition of Journal Citation Reports® cites the 2023 journal impact factor (JIF) for WJCO as 2.6; JIF without journal self cites: 2.6; 5-year JIF: 2.7; JIF Rank: 175/322 in oncology; JIF Quartile: Q3; and 5-year JIF Quartile: Q3.